(Q24650421)

English

Assessment of the absorption, metabolism and absolute bioavailability of maraviroc in healthy male subjects

scientific article

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Assessment of the absorption, metabolism and absolute bioavailability of maraviroc in healthy male subjects (English)

0 references

1 reference

Samantha Abel

1

0 references

Deborah Russell

series ordinal

2

0 references

Lyndsey A Whitlock

series ordinal

3

0 references

Caroline E Ridgway

series ordinal

4

0 references

Angus N R Nedderman

series ordinal

5

0 references

Donald K Walker

series ordinal

6

0 references

language of work or name

English

0 references

publication date

April 2008

0 references

published in

British Journal of Clinical Pharmacology

0 references

volume

65 Suppl 1

0 references

issue

s1

0 references

page(s)

60-7

0 references

cites work

A population pharmacokinetic meta-analysis of maraviroc in healthy volunteers and asymptomatic HIV-infected subjects

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2311408

retrieved

28 September 2017

Assessment of the pharmacokinetics, safety and tolerability of maraviroc, a novel CCR5 antagonist, in healthy volunteers

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2311408

retrieved

28 September 2017

Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2311408

retrieved

28 September 2017

Species differences in the disposition of the CCR5 antagonist, UK-427,857, a new potential treatment for HIV.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2008.03137.X

retrieved

21 January 2018

Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2008.03137.X

retrieved

21 January 2018

Plasma-pooling methods to increase throughput for in vivo pharmacokinetic screening

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18333867

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1111/J.1365-2125.2008.03137.X

0 references

PMC publication ID

2311408

0 references

PubMed publication ID

18333867

0 references

ResearchGate publication ID

5518128

0 references

(Q24650421)

Assessment of the absorption, metabolism and absolute bioavailability of maraviroc in healthy male subjects

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)